Fayez Sarofim & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $205M | Sell |
1,700,379
-39,510
| -2% | -$4.56M | 0.52% | 46 |
|
|
2025
Q4 | $183M | Sell |
1,739,889
-666,433
| -28% | -$62.6M | 0.44% | 50 |
|
|
2025
Q3 | $202M | Sell |
2,406,322
-214,403
| -8% | -$17.7M | 0.47% | 54 |
|
|
2025
Q2 | $207M | Sell |
2,620,725
-296,666
| -10% | -$23.6M | 0.5% | 53 |
|
|
2025
Q1 | $262M | Sell |
2,917,391
-287,516
| -9% | -$26.8M | 0.65% | 45 |
|
|
2024
Q4 | $319M | Buy |
3,204,907
+309,716
| +11% | +$31.9M | 0.77% | 39 |
|
|
2024
Q3 | $329M | Sell |
2,895,191
-26,749
| -0.9% | -$3.18M | 0.84% | 35 |
|
|
2024
Q2 | $362M | Buy |
2,921,940
+718,344
| +33% | +$92.5M | 0.98% | 29 |
|
|
2024
Q1 | $291M | Sell |
2,203,596
-209,455
| -9% | -$25.8M | 0.87% | 35 |
|
|
2023
Q4 | $303M | Sell |
2,413,051
-50,206
| -2% | -$5.21M | 0.93% | 34 |
|
|
2023
Q3 | $254M | Buy |
2,463,257
+67,646
| +3% | +$7.29M | 0.86% | 35 |
|
|
2023
Q2 | $276M | Sell |
2,395,611
-904,765
| -27% | -$103M | 0.97% | 31 |
|
|
2023
Q1 | $351M | Sell |
3,300,376
-131,058
| -4% | -$14.1M | 1.23% | 27 |
|
|
2022
Q4 | $381M | Sell |
3,431,434
-31,423
| -0.9% | -$3.21M | 1.41% | 27 |
|
|
2022
Q3 | $298M | Sell |
3,462,857
-679
| -0% | -$60.6K | 1.18% | 30 |
|
|
2022
Q2 | $316M | Buy |
3,463,536
+3,602
| +0.1% | +$319K | 1.15% | 32 |
|
|
2022
Q1 | $284M | Buy |
3,459,934
+1,409
| +0% | +$111K | 0.9% | 38 |
|
|
2021
Q4 | $265M | Buy |
3,458,525
+48,504
| +1% | +$3.86M | 0.79% | 41 |
|
|
2021
Q3 | $256M | Sell |
3,410,021
-3,177
| -0.1% | -$242K | 0.85% | 39 |
|
|
2021
Q2 | $265M | Sell |
3,413,198
-174,643
| -5% | -$13M | 0.89% | 38 |
|
|
2021
Q1 | $264M | Buy |
3,587,841
+106,990
| +3% | +$7.89M | 0.97% | 37 |
|
|
2020
Q4 | $272M | Buy |
3,480,851
+59,836
| +2% | +$4.58M | 1.04% | 35 |
|
|
2020
Q3 | $271M | Buy |
3,421,015
+24,880
| +0.7% | +$1.95M | 1.16% | 30 |
|
|
2020
Q2 | $251M | Buy |
3,396,135
+5,107
| +0.2% | +$384K | 1.16% | 33 |
|
|
2020
Q1 | $249M | Buy |
3,391,028
+106,923
| +3% | +$8.4M | 1.53% | 27 |
|
|
2019
Q4 | $285M | Buy |
3,284,105
+29,361
| +0.9% | +$2.41M | 1.37% | 28 |
|
|
2019
Q3 | $261M | Buy |
3,254,744
+24,150
| +0.7% | +$1.94M | 1.35% | 28 |
|
|
2019
Q2 | $258M | Buy |
3,230,594
+88,499
| +3% | +$6.78M | 1.34% | 27 |
|
|
2019
Q1 | $249M | Buy |
3,142,095
+21,889
| +0.7% | +$1.64M | 1.32% | 28 |
|
|
2018
Q4 | $227M | Buy |
3,120,206
+49,745
| +2% | +$3.51M | 1.37% | 26 |
|
|
2018
Q3 | $208M | Buy |
3,070,461
+10,307
| +0.3% | +$657K | 1.09% | 32 |
|
|
2018
Q2 | $177M | Buy |
3,060,154
+48,845
| +2% | +$2.76M | 0.95% | 36 |
|
|
2018
Q1 | $157M | Sell |
3,011,309
-48,767
| -2% | -$2.63M | 0.85% | 38 |
|
|
2017
Q4 | $164M | Sell |
3,060,076
-59,860
| -2% | -$3.32M | 0.85% | 38 |
|
|
2017
Q3 | $191M | Buy |
3,119,936
+2,873
| +0.1% | +$174K | 1% | 34 |
|
|
2017
Q2 | $191M | Sell |
3,117,063
-29,632
| -0.9% | -$1.8M | 1.02% | 32 |
|
|
2017
Q1 | $191M | Sell |
3,146,695
-96,694
| -3% | -$5.87M | 1.04% | 30 |
|
|
2016
Q4 | $182M | Sell |
3,243,389
-48,028
| -1% | -$2.81M | 1% | 32 |
|
|
2016
Q3 | $196M | Sell |
3,291,417
-19,986
| -0.6% | -$1.17M | 1.07% | 29 |
|
|
2016
Q2 | $182M | Buy |
3,311,403
+10,255
| +0.3% | +$546K | 1% | 31 |
|
|
2016
Q1 | $167M | Sell |
3,301,148
-39,829
| -1% | -$1.95M | 0.96% | 36 |
|
|
2015
Q4 | $168M | Sell |
3,340,977
-96,638
| -3% | -$4.87M | 0.97% | 34 |
|
|
2015
Q3 | $162M | Sell |
3,437,615
-177,643
| -5% | -$9.44M | 0.94% | 36 |
|
|
2015
Q2 | $196M | Sell |
3,615,258
-174,336
| -5% | -$9.78M | 1% | 34 |
|
|
2015
Q1 | $208M | Sell |
3,789,594
-869,289
| -19% | -$49.2M | 1.02% | 34 |
|
|
2014
Q4 | $253M | Sell |
4,658,883
-420,642
| -8% | -$23.4M | 1.2% | 25 |
|
|
2014
Q3 | $287M | Sell |
5,079,525
-119,197
| -2% | -$6.69M | 1.34% | 22 |
|
|
2014
Q2 | $287M | Sell |
5,198,722
-129,266
| -2% | -$7.05M | 1.31% | 24 |
|
|
2014
Q1 | $288M | Sell |
5,327,988
-100,340
| -2% | -$5.2M | 1.37% | 22 |
|
|
2013
Q4 | $259M | Buy |
+5,428,328
| New | +$248M | 1.2% | 30 |
|
|
2013
Q2 | $253M | Buy |
+5,697,509
| New | +$254M | 1.27% | 24 |
|
Other funds holding MRK
VCM
VPM
Fayez Sarofim & Co's MRK Position: Q1 2026 in Review
Fayez Sarofim & Co reduced its Merck (MRK) stake by 2.3% in Q1 2026, selling an estimated $4.56M and leaving 1,700,379 shares worth $205M. The position accounts for 0.52% of the portfolio, ranked #46.
Fayez Sarofim & Co first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $381M in Q4 2022. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Fayez Sarofim & Co held 1,700,379 shares of Merck worth $205M as of Q1 2026.
- Fayez Sarofim & Co sold 39,510 Merck shares in Q1 2026, an estimated $4.56M.
- Merck made up 0.52% of Fayez Sarofim & Co's portfolio in Q1 2026, its #46 holding.
- Fayez Sarofim & Co first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
- Fayez Sarofim & Co's Merck position peaked at $381M in Q4 2022.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.